In older adults with a hypoglycemia-related ER visit or hospitalization, insulin and/or sulfonylurea treatment was deintensified within 100 days in less than half of cases.
"Short-term hospitalization [for reasons other than diabetes] may not be the time to intervene in long-term diabetes management," researchers conclude.
The "twincretin" tirzepatide scored another pivotal-trial win in published results from the SURPASS-4 trial, which compared the investigational agent to insulin glargine for treatment of type 2 diabetes.
Greater increases in fasting ghrelin associated with improved metabolic benefits seen with plant-enhanced Mediterranean diet. But one commentator calls the findings simply hypothesis-generating .
Admission A1c levels of 6.8% to 7.0% were linked to lower rates of future vascular events in a new study. But optimum levels may differ among stroke subtypes, data suggest.